A recent report has renewed attention to racial disparities in cancer care in Brazil after a Black woman publicly attributed her late breast cancer diagnosis to discriminatory treatment. Her symptoms, first reported in her mid-twenties, were repeatedly minimized by physicians, delaying access to specialized evaluation and contributing to advanced disease at diagnosis. The case underscores ongoing structural barriers that disproportionately affect Black patients in screening and diagnostic pathways.

In response to these concerns, the Brazilian Society of Clinical Oncology (SBOC) has launched a new Diversity Guide aimed at promoting inclusive communication, equitable access to screening, and standardized protocols to reduce discriminatory practices. The initiative reinforces the link between early diagnosis, trust in the care pathway, and patient adherence — areas where systemic inequities continue to undermine outcomes for vulnerable groups.

Source: Folha de S.Paulo


Need to understand Brazil’s market and political landscape?

Contact Pietro Rubin pharmabrnews@gmail.com


Leave a Reply

Tendência

Discover more from PharmaBR.News

Subscribe now to keep reading and get access to the full archive.

Continue reading